Status:
COMPLETED
Long Term Bowel Function Following Rectal Cancer Surgery
Lead Sponsor:
Mansoura University
Conditions:
Bowel; Functional Syndrome
Rectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
* In this longitudinal study, 171 patients were evaluated and compared based on the radiation therapy they received. * Bowel function was assessed longitudinally with Memorial Sloan Kettering Cancer C...
Detailed Description
Background Despite advances in the neoadjuvant chemoradiation therapy and anal sphincter-preserving surgeries for rectal cancer, bowel dysfunction is still unavoidable which negatively affect the pati...
Eligibility Criteria
Inclusion
- Patients of both sexes,
- Aged between 18 and 75 years,
- Patients with mid and upper rectal cancer (6-15) cm from the anal verge(AV) with or without preoperative chemo radiotherapy.
- Patients who underwent low anterior resection(LAR).
- Patients who were followed up with at least two outpatient visits for bowel function assessment.
Exclusion
- Patients with recurrent rectal tumors,
- Surgically unfit patients,
- Patients with tumors infiltrating the puborectalis muscle or external sphincter.
- Patients with preoperative fecal incontinence.
- Patients who were followed up only once in the outpatient clinic.
- Patients with lower rectal cancer less than 6cm from AV,
- Patients who underwent abdominoperineal resection(APR) or intersphincteric resection(ISR).
Key Trial Info
Start Date :
August 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2020
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT05339763
Start Date
August 12 2019
End Date
February 25 2020
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmad
Al Mansurah, Egypt